Name: UroGen Pharma Ltd. (URGN) Balance Sheet
Creator: FinSpry

UroGen Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for UroGen Pharma Ltd. (URGN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	171.99	136.97	55.41	44.36	102.02	147.60	101.32
Short-Term Investments	64.70	41.97	44.56	44.78	49.15	0.00	0.00
Cash & Short-Term Investments	236.69	136.97	99.96	89.14	102.02	147.60	101.32
Accounts Receivable	20.30	15.44	12.70	11.72	7.05	0.00	0.00
Inventory	9.23	5.67	4.33	4.83	1.96	0.00	0.00
Other Current Assets	8.85	1.97	11.10	7.48	2.72	0.00	0.00
Total Current Assets	276.14	169.19	128.91	114.39	115.62	148.63	102.24
Non-Current Assets
Property, Plant & Equipment (Net)	3.79	2.36	3.75	3.15	4.20	4.71	0.95
Long-Term Investments	5.02	4.50	0.00	0.68	1.89	0.00	0.00
Other Non-Current Assets	0.77	2.26	2.96	1.53	0.29	0.49	0.37
Total Non-Current Assets	9.58	9.13	6.71	5.36	6.39	53.75	1.32
Total Assets	285.71	178.31	135.62	119.75	122.01	202.39	103.56
Current Liabilities
Accounts Payable	10.93	16.54	5.53	5.79	10.02	17.90	13.47
Accrued Liabilities	16.50	10.02	6.86	13.26	16.31	0.00	0.00
Other Current Liabilities	7.95	124.40	3.28	2.24	11.41	1.59	0.00
Total Current Liabilities	45.95	31.21	23.92	22.38	21.44	19.48	13.47
Non-Current Liabilities
Long-Term Debt	121.73	98.55	97.54	0.40	1.50	2.60	0.00
Deferred Tax Liabilities	0.00	0.00	3.02	2.84	0.00	0.00	0.00
Other Non-Current Liabilities	125.18	4.04	98.92	88.56	2.72	0.00	0.00
Total Non-Current Liabilities	248.57	102.59	201.06	88.95	4.21	2.60	0.00
Total Liabilities	294.51	243.52	224.98	111.33	25.65	22.09	13.47
Stockholders' Equity
Common Stock	0.12	0.09	0.06	0.06	0.06	0.00	0.00
Retained Earnings	-806.22	-679.34	-577.10	-467.32	-356.23	-228.00	-122.87
Accumulated Other Comprehensive Income	0.06	0.01	-0.11	-0.03	0.27	0.28	0.00
Additional Paid-in Capital	797.25	614.04	487.79	475.70	452.53	407.99	212.92
Shares Outstanding	42.23	32.49	23.13	22.46	0.00	0.00	0.00
Total Stockholders' Equity	-8.80	-65.21	-89.36	8.41	96.36	180.32	90.09
Total Liabilities & Equity	285.71	178.31	135.62	119.75	122.01	202.39	103.56